Antibody drug conjugates (adc) that bind to 191p4d12 proteins
US-2026034234-A1 · Feb 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Torgov Michael patents
Torgov Michael is listed as an inventor on 53 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Torgov Michael |
| Total patents | 53 |
| First publication | Feb 12, 2015 |
| Latest publication | Feb 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
US-2023346968-A1 · Nov 2, 2023 · US
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
US-11559582-B2 · Jan 24, 2023 · US
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
US-2021283268-A1 · Sep 16, 2021 · US
Light chain variable regions
US-11033634-B2 · Jun 15, 2021 · US
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
US-10894090-B2 · Jan 19, 2021 · US
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
US-RE48389-E · Jan 12, 2021 · US
Anti sez6 antibodies and methods of use
US-2020181256-A1 · Jun 11, 2020 · US
Dll3 modulators and methods of use
US-2020138969-A1 · May 7, 2020 · US
Anti SEZ6 antibodies and methods of use
US-10533051-B2 · Jan 14, 2020 · US
Recent patents
Latest publications not already listed above.
Anti-DLL3 antibody drug conjugates for treating cancer
US-10478509-B2 · Nov 19, 2019 · US
Antibody drug conjugates (adc) that bind to 161p2f10b proteins
US-2019328898-A1 · Oct 31, 2019 · US
Dll3 modulators and methods of use
US-2019247510-A1 · Aug 15, 2019 · US
Dll3 modulators and methods of use
US-2019046656-A1 · Feb 14, 2019 · US
Anti-DLL3 antibody drug conjugates for treating cancer
US-10137204-B2 · Nov 27, 2018 · US
Novel antibody conjugates and uses thereof
US-2018318441-A1 · Nov 8, 2018 · US
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
US-2018296693-A1 · Oct 18, 2018 · US
Anti-DLL3 antibody drug conjugates
US-9968687-B2 · May 15, 2018 · US
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
US-9962454-B2 · May 8, 2018 · US
Anti-DLL3 antibody drug conjugates and methods of use
US-9937268-B2 · Apr 10, 2018 · US
Methods of delivering DLL3 antibody drug conjugates
US-9931421-B2 · Apr 3, 2018 · US
Methods of making DLL3 antibody drug conjugates
US-9931420-B2 · Apr 3, 2018 · US
Methods of making dll3 antibody drug conjugates
US-2018036421-A1 · Feb 8, 2018 · US
Methods of delivering dll3 antibody drug conjugates
US-2018036422-A1 · Feb 8, 2018 · US
Methods of delivering DLL3 antibody drug conjugates
US-9878053-B2 · Jan 30, 2018 · US
Anti-dll3 antibody drug conjugates and methods of use
US-2018015178-A1 · Jan 18, 2018 · US
Anti-DLL3 antibody drug conjugates
US-9867887-B1 · Jan 16, 2018 · US
Kits containing DLL3 antibody drug conjugates
US-9861708-B2 · Jan 9, 2018 · US
Anti-DLL3 antibody drug conjugates
US-9855343-B2 · Jan 2, 2018 · US
Anti-dll3 antibody drug conjugates
US-2017368195-A1 · Dec 28, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Abbvie Stemcentrx Llc | 36 |
| Agensys Inc | 15 |
| Seattle Genetics Inc | 6 |
| Seagen Inc | 6 |
| Medimmune Ltd | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 53 |
| A61K2039/505 | 50 |
| C07K2317/565 | 47 |
| C07K2317/92 | 47 |
| C07K2317/21 | 46 |